BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/12/2024 6:40:16 AM | Browse: 38 | Download: 165
 |
Received |
|
2024-08-21 03:51 |
 |
Peer-Review Started |
|
2024-06-26 09:51 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-09-16 06:05 |
 |
Revised |
|
2024-09-26 12:04 |
 |
Second Decision |
|
2024-10-16 02:46 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-10-16 10:28 |
 |
Articles in Press |
|
2024-10-16 10:28 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2024-10-22 21:28 |
 |
Typeset the Manuscript |
|
2024-11-01 08:45 |
 |
Publish the Manuscript Online |
|
2024-11-12 06:40 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Editorial |
Article Title |
Irreversible electroporation for metastatic pancreatic carcinoma with liver metastasis: What does the evidence say
|
Manuscript Source |
Invited Manuscript |
All Author List |
Ranit Seal, Akash Bararia, Bitan kumar Chattopadhyay and Nilabja Sikdar |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Department of Biotechnology, Government of India |
No. RLS/BT/Re-entry/05/2012 |
|
Corresponding Author |
Nilabja Sikdar, PhD, Human Genetics Unit, Indian Statistical Institute, 203 BT Road, Kolkata 700108, West Bengal, India. snilabja@gmail.com |
Key Words |
Irreversible electroporation; Locally advanced pancreatic carcinoma; Metastatic pancreatic carcinoma; Advanced pancreatic carcinoma; Chemotherapy |
Core Tip |
Irreversible electroporation (IRE) is a non-thermal ablation technique that has shown promise in increasing survival for locally advanced pancreatic carcinoma when combined with chemotherapy. However, its efficacy in metastatic pancreatic carcinoma with liver metastasis is not yet established, and further high-quality studies with proper controls and randomization are needed. IRE has advantages over other ablation methods, such as preserving neighboring structures and avoiding the heat-sink effect, but it requires careful patient selection and has potential complications. The procedure is typically performed under general anesthesia and has several contraindications. While IRE may offer a new frontier in treating pancreatic cancer, its role in metastatic disease requires more research to confirm its benefits. |
Publish Date |
2024-11-12 06:40 |
Citation |
<p>Seal R, Bararia A, Chattopadhyay BK, Sikdar N. Irreversible electroporation for metastatic pancreatic carcinoma with liver metastasis: What does the evidence say. <i>World J Clin Cases</i> 2025; 13(3): 98452</p> |
URL |
https://www.wjgnet.com/2307-8960/full/v13/i3/98452.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v13.i3.98452 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345